Endothelial nitric oxide synthase-dependent tyrosine nitration of prostacyclin synthase in diabetes in vivo

Diabetes

Volumn 55, Issue 11, 2006, Pages 3133-3141

  Nie, Hong ^a   Wu, Ji Liang ^b   Zhang, Miao ^c   Xu, Jian ^c   Zou, Ming Hui ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; INDOMETACIN; MANNITOL; PROSTACYCLIN SYNTHASE; SEPIAPTERIN; SUPEROXIDE; TYROSINE;

ANIMAL EXPERIMENT; ARTICLE; CORONARY ARTERY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IN VIVO STUDY; MALE; MOUSE; NITRATION; NONHUMAN; PRIORITY JOURNAL; VASOCONSTRICTION; VASOSPASM;

ANIMALS; AORTA; CYTOCHROME P-450 ENZYME SYSTEM; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; HUMANS; HYPERGLYCEMIA; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NITRIC OXIDE SYNTHASE TYPE III; REACTIVE NITROGEN SPECIES; SUPEROXIDE DISMUTASE; SUPEROXIDES; TYROSINE; VASODILATION;

EID: 33845532813     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0505     Document Type: Article

References (40)

1. Zou MH, Ullrich V, Cohen R: Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 11:89-97, 2004
2. Ruderman NB, Williamson JR, Brownlee M: Glucose and diabetic vascular disease. FASEB J 6:2905-2914, 1992
3. Cohen RA: Role of nitric oxide in diabetic complications. Am J Ther 12:499-502, 2005
4. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001
5. 2 receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51:198-203, 2002
6. Zou MH, Shi S, Cohen RA: Oxidation by peroxynitrite of zinc-thiolate cluster of eNOS uncouples the enzyme in diabetes. J Clin Invest 109:817-826, 2002
7. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87:1620-1624, 1990
8. Beckman JS, Chen J, Ischiropoulos H, Crow JP: Oxidative chemistry of peroxynitrite. Methods Enzymol 233:229-240, 1994
9. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 271:C1424-C1437, 1996
10. Moncada S, Vane JR: Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev 30:292-331, 1979
11. Moncada S: Biological importance of prostacyclin. Br J Pharmacol 76:3-31, 1982
12. Dollery CT, Friedman LA, Hensby CN, Kohner E, Lewis PJ, Porta M, Webster J: Circulating prostacyclin may be reduced in diabetes. Lancet ii:1365, 1979
13. Johnson M, Harrison HE, Raftery AT, Elder JB: Vascular prostacyclin may be reduced in diabetes in man. Lancet i:325-326, 1979
14. Silberbauer K, Schernthaner G, Sinzinger H, Piza-Katzer H, Winter M: Decreased vascular prostacyclin in juvenile-onset diabetes. N Engl J Med 300:366-367, 1979
15. 2) synthesis. Artery 8:30-36, 1980
16. Tesfamarian B, Brown ML, Cohen RA: Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87:1643-1648, 1991
17. 2 as an endothelium-derived contracting factor in diabetic state. Diabetes 42:1246-1252, 1993
18. Dai FX, Diederich A, Skopec J, Diederich D: Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: role of prostaglandin endoperoxides and free radicals. J Am Soc Nephrol 4:1327-1336, 1993
19. 2 receptors in streptozotocin-induced diabetes: effects of insulin therapy in the rat. Prostaglandins 45:427-438, 1993
20. Zou MH, Ullrich V: Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase. FEBS Lett 382:101-104, 1996
21. Zou MH, Martin C, Ullrich V: Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol Chem 378:707-713, 1997
22. Zou M, Jendral M, Ullrich V: Peroxynitrite induces prostaglandin endoperoxide dependent-vasospasm in bovine coronary arteries via nitration of prostacyclin synthase. Br J Pharmacol 126:1283-1292, 1999
23. Zou MH, Bachschmid M: Hypoxia-reoxygenation causes coronary vasospasm via tyrosine nitration of prostacyclin synthase. J Exp Med 190:135-139, 1999
24. Davis B, Zou MH: CD40Ligand (CD40L)-dependent tyrosine nitration of prostacyclin synthase in vivo. Circulation 112:2184-2192, 2005
25. Schmidt P, Youhnovski N, Daiber A, Balan A, Arsic M, Bachschmid M, Przybylski M, Ullrich V: Specific nitration at tyrosine 430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase. J Biol Chem 278:12813-12819, 2003
26. Skatchkov MP, Sperling D, Hink U, Mulsch A, Harrison DG, Sindermann I, Meinertz T, Munzel T: Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. Biochem Biophys Res Commun 254:319-324, 1999
27. Mais DE, Saussy DL, Chaikouni A, Kochel PJ, Knapp DR, Hamanaka N, Halushka PV: Pharmacological characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. J Pharmacol Exp Ther 233:418-424, 1985
28. Ogletree M, Harris DN, Greenberg R, Haslanger MF, Nakane M: Pharmacological actions of SQ29548, a novel selective thromboxane antagonist. J Pharmacol Exp Ther 234:435-441, 1985
29. Griendling KK, Sorescu D, Ushio-Fukai M: NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86:494-501, 2000
30. Hande KR, Chabner BA: A competitive protein binding assay for allopurinol and oxipurinol. Anal Biochem 101:26-33, 1980
31. Vasquez-Vivar J, Kalyanaraman B, Martasek P: The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications. Free Radic Res 37:121-127, 2003
32. Alp NJ, Channon KM: Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 24:413-420, 2004
33. Baker TA, Milstien S, Katusic ZS: Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells. J Cardiovasc Pharmacol 37:333-338, 2001
34. Mata-Greenwood E, Jenkins C, Farrow KN, Konduri GG, Russell JA, Lakshminrusimha S, Black SM, Steinhorn RH: eNOS function is developmentally regulated: uncoupling of eNOS occurs postnatally. Am J Physiol Lung Cell Mol Physiol 290:L232-L241, 2006
35. Spisni E, Griffoni C, Santi S, Riccio M, Marulli R, Bartolini G, Toni M, Ullrich V, Tomasi V: Colocalization prostacyclin (PGI2) synthase-caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis. Exp Cell Res 266:31-43, 2001
36. Everson WV, Smart EJ: Influence of caveolin, cholesterol, and lipoproteins on nitric oxide synthase: implications for vascular disease. Trends Cardiovasc Med 11:246-250, 2001
37. Shaul PW: Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 64:749-774, 2002
38. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Villet A: Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391:391-397, 1998
39. van der Vliet A, Eiserich JP, O'Neill CA, Halliwell B, Cross CE: Tyrosine modification by reactive nitrogen species: a closer look. Arch Biochem Biophys 319:341-349, 1995
40. Cosentino F, Lüscher TF: Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 32:S54-S61, 1998